NCT05600179View on ClinicalTrials.gov

OCTA in Epivascular Glia After Dex Implant

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Diabetic Retinopathy
Interventions
DRUG

Dexamethasone intravitreal implant

Dexamethasone intravitreal implant

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT05600179 - OCTA in Epivascular Glia After Dex Implant | Biotech Hunter | Biotech Hunter